A 56-year-old woman treated by dermatologist with diagnosis of rosacea for 3 months was referred to our department. First, lesions appeared 6 months ago on her face as numerous teleangiectatic papules (Fig. 1a) , and then 2 months ago, new nodular lesions developed on her arms and back (Fig. 1c) . Patient was in good general condition, occupationally active, and skin lesions did not provoke any subjective symptoms. Physical examination revealed enlarged lymph nodes in both armpits, no other abnormalities. Laboratory parameters showed lymphocytosis-white blood cells count 46.480×10 9 /L with 87% of lymphocytes in blood smear, also Gumprecht shadows were present. Other peripheral blood (PB) parameters and laboratory tests were in normal ranges. Lesional skin biopsy from face and arm revealed dermal infiltration of small, round, monomorphous lymphocytes with scant cytoplasm and clumped chromatin. Phenotypic studies identified these cells as Bcell lineage with multiple cells positive for bcl-2 and Ki67. Results of flow cytometry of the PB were consistent with B-CLL-87%% of CD19+ lymphocytes were positive for CD5 and 71% positive for CD23. Bone marrow biopsy also confirmed the suspicion of B-CLL-85% of mature lymphocytes, in FISH examination-monosomy of chromosome 17. Full-body CT scan excluded involvement of the internal systems, and a diagnosis of B-CLL in stage Rai I was made. Patient was qualified to the combined treatment (RCC)-rituximab 600 mg i.v. (375 mg/m2) in cycle 1 and 800 mg i.v. (500 mg/m2) in cycles 2-6, cladribine 7 mg i.v., and cyclophosphamide 400 mg i.v. in each cycle. After two cycles of chemotherapy, skin lesions almost completely resolved (Fig. 1b, d ), PB parameters were in normal range, and no lymph nodes enlargement was observed. Patient still receives treatment and remains under control of the hematologists.
In conclusion, to our knowledge, this is the first case of B-CLL LC treated successfully with RCC regimen. The other interesting point is misdiagnosed disease and treatment for rosacea that was conducted by two dermatologists. The specific solitary skin lesions in B-CLL are rare and, especially as the first claimed by patient symptom, may be misdiagnosed. 
